Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

2009128 citationsJournal Articlehybrid Open Access

Authors

Although low-dose enoximone appears to be safe in patients with advanced HF, major clinical outcomes are not improved.

Good health and well-being

Published in: European Heart Journal

Volume 30, Issue 24, pp. 3015-3026

Field-Weighted Citation Impact: 5.39